Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis

Although the effect of levocarnitine (L‐carnitine) on hyperammonemia has been reported in patients with liver cirrhosis (LC), its effect on sarcopenia remains to be elucidated. We assessed the effects of L‐carnitine on sarcopenia in patients with LC. We retrospectively evaluated 52 patients with LC...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Hepatol Commun
Autori principali: Hiramatsu, Akira, Aikata, Hiroshi, Uchikawa, Shinsuke, Ohya, Kazuki, Kodama, Kenichiro, Nishida, Yuno, Daijo, Kana, Osawa, Mitsutaka, Teraoka, Yuji, Honda, Fumi, Inagaki, Yuki, Morio, Kei, Morio, Reona, Fujino, Hatsue, Nakahara, Takashi, Murakami, Eisuke, Yamauchi, Masami, Kawaoka, Tomokazu, Miki, Daiki, Tsuge, Masataka, Imamura, Michio, Tanaka, Junko, Chayama, Kazuaki
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2019
Soggetti:
Brief Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6396356/
https://ncbi.nlm.nih.gov/pubmed/30859147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1309
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi